News
Public · Published
Cantor Fitzgerald maintains Rocket Lab at Overweight, lowers price target to $111 from $122
Cantor Fitzgerald kept its Overweight rating on Rocket Lab but lowered its price target to $111 from $122, a 9.0% decrease. The article says the new target implies 88.6% upside from the November 9 closing price of $58.86.
Published:
Updated:
What happened
Cantor Fitzgerald kept its Overweight rating on Rocket Lab but lowered its price target to $111 from $122, a 9.0% decrease. The article says the new target implies 88.6% upside from the November 9 closing price of $58.86.
Confirmed
Global impact / market context
The lower target signals that Cantor Fitzgerald sees less potential value than before, even while retaining its positive rating. If investors reassess expected returns, their willingness to buy or hold Rocket Lab shares could change, affecting the company’s share price and its ability to raise funds through stock sales.
Analyst inference
The article lists four recent analyst targets ranging from $90 to $122, including Cantor Fitzgerald’s earlier $122 target. The new $111 target remains within that range, so it changes one analyst’s view without establishing a broader shift in analyst expectations.
Analyst inference
What to watch
- Watch for further Cantor Fitzgerald updates: another target change or a rating change would show whether this lower estimate is part of a continuing reassessment. Analyst inference
- Compare any new analyst targets with the reported $90-to-$122 range; a wider spread would indicate less agreement about Rocket Lab’s expected share value. Analyst inference
- Check Rocket Lab’s share price against the article’s November 9 close of $58.86; the stated 88.6% upside is based on that reference price. Confirmed
Evidence
- Original source link unavailable